Results 21 to 30 of about 205,027 (361)
Progress of clinical therapies for dry age-related macular degeneration [PDF]
International Journal of Ophthalmology, 2022 Dry age-related macular degeneration (AMD) is a progressive blinding disease that currently affects millions of people worldwide with no successful treatment available.
Rhianna Rubner +2 more
doaj +1 more source
Dry age-related macular degeneration - therapeutic possibilities and research directions [PDF]
Farmacja Polska, 2022 Age-related macular degeneration (AMD) is a major cause of vision loss in developed countries, especially in the elderly population. AMD is a multifactorial disease which etiology is not completely understood.
Alicja Zajdel
doaj +1 more source
Sleep, Pain, and Neurodegeneration: A Mendelian Randomization Study
Frontiers in Neurology, 2022 Our aim was to determine whether the genetic liability to sleep and pain-related traits have a causal effect on risk of neurodegeneration in individuals of predominantly European ancestry. We selected five neurodegenerative disorders, namely, age-related
Sandeep Grover +2 more
doaj +1 more source
Age-Related Macular Degeneration and Circadian Preference [PDF]
Clinical OphthalmologyEstefany Garces,1 Katarzyna Slota,2 Michael W Stewart,3 Maria P Guzman,4 Natalia M Werninck,1 Pablo R Castillo1 1Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA; 2Northwest Community ...
Garces E +5 more
doaj +2 more sources
Age-related macular degeneration [PDF]
Journal of the Royal Society of Medicine, 2009 Age-related macular degeneration (AMD) is a significant source of morbidity in aging adults. The damage to the macula and vision loss in advanced forms of wet AMD stems from choroidal neovascularization that originates in the choroid and proliferates through breaks in the Bruch membrane. Although inhibitors of angiogenesis have been a recent advance in
Tariq, Ayoub, Nishal, Patel
+6 more sources
PLoS ONE, 2021 ObjectiveThis study aimed to investigate the risk of Alzheimer's disease among patients with age-related macular degeneration and its association with confounding comorbidities.MethodThis was a population-based, retrospective cohort study.
Li-Yen Wen +9 more
doaj +1 more source
BMC Ophthalmology, 2023 Background The aim of this study was to describe features of disease activity in patients with treated stable macular neovascularisation (MNV) in neovascular age related macular degeneration (nAMD) using optical coherence tomography angiography (OCTA ...
Daren Hanumunthadu +6 more
doaj +1 more source
Innate immune biology in age-related macular degeneration
Frontiers in Cell and Developmental Biology, 2023 Age-related macular degeneration (AMD) is a neurodegenerative disease and a leading cause of irreversible vision loss in the developed world. While not classically described as an inflammatory disease, a growing body of evidence has implicated several ...
Karina Ascunce +4 more
doaj +1 more source
Morphometric analyses of the visual pathways in macular degeneration [PDF]
, 2014 Introduction. Macular degeneration (MD) causes central visual field loss. When field defects occur in both eyes and overlap, parts of the visual pathways are no longer stimulated.
Baseler, Heidi A. +8 more
core +6 more sources
Neuroprotection for Age-Related Macular Degeneration
Ophthalmology Science, 2022 Age-related macular degeneration (AMD) is a leading cause of blindness worldwide. Early to intermediate AMD is characterized by the accumulation of lipid- and protein-rich drusen.
Jonathan B. Lin, MD, PhD +3 more
doaj +1 more source